Forming a network of clinicians and scientists

The Nordic AML Group (NAMLG) aim to foster excellence in research and clinical care in acute myeloid leukemia (AML) in the Nordic countries, by forming an active network of clinicians and basic and translational scientists with deep interest and experience in the field.

Photo: NASA

News from NAMLG

[News? Please, let us know via namlgewg@gmail.com.]

Ex Vivo Venetoclax Sensitivity Predicts Clinical Response in AML in the Prospective VenEx Trial

Results from the Finnish VenEx trial (NCT04267081) have now been published in Blood. You can find the publication by using this link.

Webinar recording – Aza-Ven – Recent clinical updates 2024-09-24

NAMLG arranged a webinar 2024-09-24 on the topic “Aza-Ven: recent clinical updates”.

You can find a recording of the webinar using this link.

Upcoming events

[Have an event? Please, let us know via namlgewg@gmail.com.]

Evolving treatment options for patients with AML ineligible for intensive chemotherapy

Find more info in this flyer. Location: Aarhus University Hospital AUH SYD, auditorium C114-101. Indgang C, C110 or join online. Please send your registration for the meeting before October 16th […]

Find out more »

AML Course Day 10 September 2025

The Educational Working Group is planning an "AML Course Day" in conjunction with the Nordic AML Meeting in Bergen 2025. The AML Course Day covers topics such as the current […]

Find out more »

Nordic AML Meeting 11-12 September 2025

Save the dates for the upcoming Nordic AML Meeting in Bergen, Norway, 2025.

Find out more »

All Upcoming Events

All

Click here to add your own text